How Should Investors View Ocugen Inc. (OCGN) Insider Trading?

As of Friday close, Ocugen Inc.’s (NASDAQ:OCGN) stock was up $0.19, moving up 9.95 percent to $2.10. The average number of shares traded per day over the past five days has been 9,243,880 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0600 fall in that time frame. In the last twenty days, the average volume was 7,407,650, while in the previous 50 days, it was 9,690,262.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


Since last month, OCGN stock retreated -29.29%. Shares of the company fell to $1.6700 on 05/12/22, the lowest level in the past month. A 52-week high of $17.65 was reached on 01/03/22 after having rallying from a 52-week low of $1.67. Since the beginning of this year, OCGN’s stock price has dropped by -53.85% or -$2.4500, and marked a new high 1 time. However, the stock has declined by -88.10% since its 52-week high.

Ocugen Inc. (OCGN) last reported insider trading activity 1 day ago on May 13. Musunuri Shankar, the Chief Executive Officer of the company, disposed of 125,000 shares for $1.92 on May 13. It resulted in a $240,000 divestment by the insider. Kumar Ramesh sold 7,500 shares at an average price of $2.83 on Apr 18. The insider now owns 0 shares following the transaction. On Mar 16, Chief Executive Officer Musunuri Shankar sold 81,823 shares at $2.65 apiece. The transaction was valued at $216,831.

Financial Health

In the three months ended September 29, Ocugen Inc.’s quick ratio stood at 14.70, while its current ratio was 14.70, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.02, and the total debt-to-equity ratio was 0.02. Based on annual data, OCGN earned $58.03 million in gross profit.

In Ocugen Inc.’s quarter-end financial report for September 29, it reported total debt of $1.73 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. While analysts expected Ocugen Inc. to report -$0.04 quarterly earnings, the actual figure was -$0.05 per share, beating the consensus estimate by -25.00%. During the quarter, the company generated -$17.96 million in EBITDA. The liabilities of Ocugen Inc. were 10.6 million at the end of its most recent quarter ended September 29, and its total debt was $3.15 million. The value of shareholders’ equity is $215.66 million.

Technical Picture

This quick technical analysis looks at Ocugen Inc.’s (OCGN) price momentum. With a historical volatility rate of 125.03%, the RSI 9-day stood at 43.03% on 13 May.

With respect to its five-day moving average, the current Ocugen Inc. price is down by -2.78% percent or -$0.0600. At present, OCGN shares trade -23.91% below its 20-day simple moving average and -59.38% percent below its 100-day simple moving average. However, the stock is currently trading approximately -36.17% below its SMA50 and -69.21% below its SMA200.

Stochastic coefficient K was 26.75% and Stochastic coefficient D was 18.52%, while ATR was 0.2500. Given the Stochastic reading of 50.59% for the 14-day period, the RSI (14) reading has been calculated as 41.10%. As of today, the MACD Oscillator reading stands at -0.2000, while the 14-day reading stands at -0.2400.

Analyst Ratings

Noble Capital Markets launched its rating on Ocugen Inc. (NASDAQ: OCGN) to an Outperform in a note to investors on July 26, 2021. Ocugen Inc. (OCGN) has been rated Overweight by analysts. According to 0 brokerage firms, OCGN is a sell, and 2 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Ocugen Inc. stock as buy, with 2 recommending it as overweight.

With a median target price of $5.50, the current consensus forecast for the stock is $3.50 – $15.00. Based on these forecasts, analysts predict Ocugen Inc. (OCGN) will achieve an average price target of $7.38.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles